Table 2. Pharmacokinetic parameters after single oral dose of curcumin preparations.
| Preparation | TS-P1 capsule | CR-043P capsule | CR-033P capsule | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AUC0–24h | AUC0–12h | AUC0–24h dose adjusted | Cmax | tmax | T1/2 (complete case) | AUC0–24h | AUC0–12h | AUC0–24h dose adjusted | Cmax | tmax | T1/2 (complete case) | AUC0–24h | AUC0–12h | AUC0–24h dose adjusted | Cmax | tmax | T1/2 (complete case) | |
| (ng/mL×h) | (ng/mL×h) | (ng/mL×h) | (ng/mL) | (h) | (h) | (ng/mL×h) | (ng/mL×h) | (ng/mL×h) | (ng/mL) | (h) | (h) | (ng/mL×h) | (ng/mL×h) | (ng/mL×h) | (ng/mL) | (h) | (h) | |
| Mean | 1,168.88 | 889.76 | 25.98 | 179.91 | 2.18 | 6.23 | 1,247.32 | 739.46 | 13.86 | 104.90 | 6.59 | 10.18 | 1,345.39 | 837.56 | 14.95 | 108.60 | 6.50 | 8.89 |
| SD | 635.95 | 491.80 | 14.13 | 109.67 | 1.33 | 2.70 | 615.40 | 406.49 | 6.84 | 85.79 | 5.22 | 3.86 | 580.35 | 397.43 | 6.45 | 54.68 | 2.65 | 4.07 |
| Geometric mean | 1,036.81 | 791.16 | 23.04 | 152.63 | 1.82 | 5.72 | 1,092.63 | 648.13 | 12.14 | 85.95 | 4.88 | 10.03 | 1,235.61 | 762.92 | 13.73 | 97.59 | 5.76 | 8.60 |
| Median | 953.62 | 724.56 | 21.19 | 162.78 | 2.00 | 5.85 | 1,179.90 | 675.37 | 13.11 | 96.24 | 4.00 | 10.46 | 1,307.31 | 795.71 | 14.53 | 100.83 | 8.00 | 8.16 |
| Min. | 511.97 | 414.89 | 11.38 | 55.73 | 1.0 | 2.38 | 204.41 | 156.35 | 2.27 | 18.03 | 1.0 | 5.42 | 503.12 | 397.94 | 5.59 | 43.69 | 1.0 | 4.12 |
| Max. | 2,756.17 | 2,202.85 | 61.25 | 500.37 | 4.0 | 14.37 | 2,894.74 | 2,111.02 | 32.16 | 454.30 | 24.0 | 18.25 | 3,031.31 | 2,116.61 | 33.68 | 281.91 | 12.0 | 15.97 |